Department of Endocrinology, China-Japan Friendship Hospital, Beijing, China.
J Diabetes Investig. 2018 Nov;9(6):1237-1238. doi: 10.1111/jdi.12871. Epub 2018 Jul 9.
Metabolic surgery is an effective treatment option for obese patients with type 2 diabetes mellitus (T2DM). Frequent relapses and significantly decreased remission rates have been started after 10 and 15 years in surgically treated patients. Further concern should be warranted on predictors related to gastrointestinal hormones and metabolic profile of long-term remission and relapse of T2DM following metabolic surgery in obese patients.
代谢手术是肥胖 2 型糖尿病(T2DM)患者的有效治疗选择。手术后 10 年和 15 年,患者的复发率频繁且明显降低。对于肥胖患者代谢手术后 T2DM 长期缓解和复发与胃肠道激素和代谢特征相关的预测因素,应进一步引起关注。